Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Keryx Biopharmaceuticals, Inc. (NQ: KERX)
7.660 USD  +0.100 (+1.32%)
Official Closing Price  /  Updated: 4:00 PM EDT, Jun 18, 2013  /  Add to My Watchlist      
View: Quote News Research
All news about Keryx Biopharmaceuticals, Inc.
 
< Previous 1 2
...
31 32 33 34 35 36 37 38 Next >
Drug stocks slip; Lundbeck tumbles on studies
June 08, 2009
Drug stocks slip in early action as shares of H. Lundbeck A/S tumble on news that late-stage clinical studies for its antidepressant LuAA21004 had yielded disappointing results. Read More
category Biotechnology , $DRG , HLUKY , and 7 more.
from MarketWatch
Morning Movers 6/8: ANPI, MITI, KERX, DYAX, MSPD, MNKD Higher; AIB, LYG, XTNT, IRE Lower
June 08, 2009
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=4714145 for the full story. Read More
from StreetInsider.com News Articles
WallStSense.com Free Research Report for Shareholders of LVS, CVX, MDT and KERX
June 08, 2009
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by WallStSense.com Read More
from Marketwired News Releases
ANPI, STEM, CTIC, KERX, XOMA, MITI, MBRX See Volume and Upside Price Action
June 08, 2009
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=4714064 for the full story. Read More
from StreetInsider.com News Articles
Keryx Biopharmaceuticals (KERX) Announces Positive Phase 2 Study of Zerenex
June 08, 2009
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=4713807 for the full story. Read More
from StreetInsider.com News Articles
Keryx Biopharmaceuticals Reports Positive Phase 2 Study Results of Zerenex (Ferric Citrate) for the Treatment of Hyperphosphatemia in End-Stage Renal Disease Patients
June 08, 2009
from PR Newswire
Top 10 News Items 6/1-6/5: GM IS BANKRUPT; Jobs Report Comes in Much Better-Than-Expected; Equity Offerings Still All The Rage
June 05, 2009
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=4712818 for the full story. Read More
from StreetInsider.com News Articles
PennyStockChaser.com Announces Stock to Watch: KERX, IGOI, IMOS, HILL, IGC and GNBT
June 01, 2009
from PR Newswire
Morning Movers 6/1: KERX, AGEN, ETWC, EGOV Higher; ABIO, THLD, SNTA, OGXI Lower
June 01, 2009
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=4695557 for the full story. Read More
from StreetInsider.com News Articles
Beacon Equity Issues Stock Alerts on Monday's Market Movers
June 01, 2009
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by Beacon Equity Research Read More
from Marketwired News Releases
Keryx Biopharma (KERX) Announces Data on KRX-0401 at ASCO
June 01, 2009
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=4695085 for the full story. Read More
from StreetInsider.com News Articles
AEterna Zentaris Partner Keryx Reports Positive Phase 2 Data for Perifosine (KRX-0401) in Colon and Kidney Cancer at ASCO Meeting
June 01, 2009
from PR Newswire
Keryx Biopharmaceuticals Announces Positive Data from a Randomized, Multi-Center, Placebo-Controlled, Phase 2 Combination Study of KRX-0401 (Perifosine) in the Treatment of Advanced Metastatic Colon C
June 01, 2009
from PR Newswire
AllPennyStocks.com Canadian Penny Stocks in Play for June 1, 2009 (FDC.V, AEZ.TO)
June 01, 2009
from ACCESSWIRE
Keryx Biopharmaceuticals Reports Positive Data from a Randomized, Multi-Center, Placebo-Controlled, Phase 2 Combination Study of KRX-0401 (Perifosine) in the Treatment of Advanced Metastatic Colon Can
May 31, 2009
from PR Newswire
Keryx Biopharmaceuticals Reports Single Agent Phase 2 Data of KRX-0401 (Perifosine) Further Demonstrating KRX-0401's Activity in the Treatment of Advanced Metastatic Renal Cell Cancer
May 29, 2009
from PR Newswire
Today's Alerts Include: LEAP, KERX, FREE, ETFC, COST
May 28, 2009
from PR Newswire
PennyStockChaser.com Announces Stock to Watch: CGAQ up 200%, EXBX, SACQW, KERX, ZQK and CAR
May 27, 2009
from PR Newswire
Keryx Bio (KERX) Chairman Buys 40K Shares
May 27, 2009
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=4685761 for the full story. Read More
from StreetInsider.com News Articles
Keryx Biopharmaceuticals Announces Appointment of Ron Bentsur as Chief Executive Officer
May 20, 2009
from PR Newswire
Keryx Biopharmaceuticals Announces Poster Presentations Highlighting Clinical Activity of KRX-0401 (Perifosine) at the Upcoming Annual Meeting of the American Society of Clinical Oncology
May 18, 2009
from PR Newswire
MaybachFinancial.com Posts Free Analyst Report on SFL, XTXI, KERX and NVLS
May 15, 2009
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by Maybach Read More
from Marketwired News Releases
Morning Movers 5/14: KERX, PMII, WH, CSKI Higher; LEA, BEXP, ANW, FIG, ENS Lower
May 14, 2009
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=4650158 for the full story. Read More
from StreetInsider.com News Articles
Keryx Biopharmaceuticals (KERX) Swings to Q1 Profit
May 14, 2009
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=4649911 for the full story. Read More
from StreetInsider.com News Articles
Keryx Biopharmaceuticals, Inc. Announces First Quarter 2009 Financial Results
May 13, 2009
from PR Newswire
Keryx Biopharmaceuticals, Inc. to Hold Conference Call on First Quarter 2009 Financial Results on Thursday, May 14, 2009 at 8:30am EDT
May 11, 2009
from PR Newswire
Keryx Biopharmaceuticals, Inc. Announces Michael P. Tarnok as Interim Chairman and Chief Executive Officer
April 23, 2009
from PR Newswire
Keryx Biopharmaceuticals Presents Encouraging Preclinical Data at Annual Meeting of the American Association of Cancer Research
April 21, 2009
from PR Newswire
Keryx Biopharmaceuticals (KERX) Tops Q4 EPS by 5c; CEO Comments on Outlook
March 12, 2009
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=4482941 for the full story. Read More
from StreetInsider.com News Articles
Keryx Biopharmaceuticals, Inc. Announces Fourth Quarter and Year-End 2008 Financial Results
March 12, 2009
from PR Newswire
< Previous 1 2
...
31 32 33 34 35 36 37 38 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here